Eskalith is composed of active component Lithium Carbonate indicated for the treatment of a manic-depressive disorder or bipolar disorder. It is manufactured by one of the growing pharmaceutical companies, GSK pharmaceuticals. It is offered in a conventional tablet form and available in a dosage of 300 mg.
Active Ingredient: Lithium Carbonate is the main active component in this medicine. It shows antimanic and hematopoietic activities. This active component interferes with transmembrane sodium exchange in nerve cells via affecting sodium, potassium-stimulated adenosine triphosphatase. It alters the release of neurotransmitters that affects cyclic adenosine monophosphate concentrations and blocks inositol metabolism. This process leads to the depletion of cellular inositol and inhibition of phospholipase C-mediated signal transduction.
Indications: Given medication is indicated to treat a manic-depressive disorder or bipolar disorder. It acts to stabilize the mood and reduce extremes in behavior. Eskalith does this by restoring the balance of certain natural substances i.e. neurotransmitters in the brain.
Action Mechanism: This medication works to stabilize the mood and reduce unusual behavior. It restores the balance of certain natural substances in the brain. Eskalith may decrease how often manic episodes occur and decrease the symptoms of manic episodes, like exaggerated feelings of well-being, feelings that others wish to harm you, irritability, anxiousness, rapid/loud speech, and aggressive/hostile behaviors.
Dosages: This effective medicine is available for oral consumption in dosage as follows:
- 300 mg: It should be administered 3 to 4 times a day in adults and 2 to 3 times in children as directed by the doctor
Note: Drink 8 to 12 glasses of water or fluid each day, and consume a healthy diet with normal amounts of salt as advised by the doctor or dietician while treating with this medication. Avoid changing the amount of salt in the diet unless the doctor directed for the same.